BRCA1 A10.2 gRNA Citations (1)

Originally described in: Large-Scale Analysis of CRISPR/Cas9 Cell-Cycle Knockouts Reveals the Diversity of p53-Dependent Responses to Cell-Cycle Defects.
McKinley KL, Cheeseman IM Dev Cell. 2017 Feb 27;40(4):405-420.e2. doi: 10.1016/j.devcel.2017.01.012. Epub 2017 Feb 16. PubMed Journal

---

Articles Citing BRCA1 A10.2 gRNA

Articles
S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy. Li J, Shu X, Xu J, Su SM, Chan UI, Mo L, Liu J, Zhang X, Adhav R, Chen Q, Wang Y, An T, Zhang X, Lyu X, Li X, Lei JH, Miao K, Sun H, Xing F, Zhang A, Deng C, Xu X. Nat Commun. 2022 Mar 18;13(1):1481. doi: 10.1038/s41467-022-29151-5. PubMed

If you have published an article using this material, please email us at to have your article added to this page.